Notably, heightened serum IL-6 levels post-periodontal therapy in T1DM patients were linked to poorer periodontal healing responses, suggesting a potential modulation of the host immune response by IL-6 in T1DM patients [81]. This evidence concerns the gene IL6 and type 1 diabetes mellitus.